These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 21399456

  • 1. New therapeutic options in rheumatoid arthritis: a focus on interleukin-6 blockade.
    Furfaro N.
    J Infus Nurs; 2011; 34(2):107-15. PubMed ID: 21399456
    [Abstract] [Full Text] [Related]

  • 2. Tocilizumab: new drug. Rheumatoid arthritis: another 'mab', no therapeutic advantage.
    Prescrire Int; 2009 Oct; 18(103):198-201. PubMed ID: 19882783
    [Abstract] [Full Text] [Related]

  • 3. New therapies for treatment of rheumatoid arthritis.
    Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P.
    Lancet; 2007 Dec 01; 370(9602):1861-74. PubMed ID: 17570481
    [Abstract] [Full Text] [Related]

  • 4. Use of biologics in rheumatoid arthritis: where are we going?
    Pucino F, Harbus PT, Goldbach-Mansky R.
    Am J Health Syst Pharm; 2006 Sep 15; 63(18 Suppl 4):S19-41. PubMed ID: 16960244
    [Abstract] [Full Text] [Related]

  • 5. The efficacy and tolerability of newer biologics in rheumatoid arthritis: best current evidence.
    Siddiqui MA.
    Curr Opin Rheumatol; 2007 May 15; 19(3):308-13. PubMed ID: 17414961
    [Abstract] [Full Text] [Related]

  • 6. [Indications and efficacy of biologics in inflammatory arthritis].
    Combe B.
    Bull Acad Natl Med; 2012 Oct 15; 196(7):1279-92; discussion 1293. PubMed ID: 23815014
    [Abstract] [Full Text] [Related]

  • 7. Biologic therapy for rheumatoid arthritis: clinical efficacy and predictors of response.
    Gibbons LJ, Hyrich KL.
    BioDrugs; 2009 Oct 15; 23(2):111-24. PubMed ID: 19489652
    [Abstract] [Full Text] [Related]

  • 8. [Rheumatoid polyarthritis: a new treatment].
    Perspect Infirm; 2010 Oct 15; 7(5):46-7. PubMed ID: 21744636
    [No Abstract] [Full Text] [Related]

  • 9. Tuberculosis risk in patients treated with non-anti-tumor necrosis factor-α (TNF-α) targeted biologics and recently licensed TNF-α inhibitors: data from clinical trials and national registries.
    Cantini F, Niccoli L, Goletti D.
    J Rheumatol Suppl; 2014 May 15; 91():56-64. PubMed ID: 24789001
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonists.
    Isaacs JD.
    Expert Opin Biol Ther; 2009 Dec 15; 9(12):1463-75. PubMed ID: 19916731
    [Abstract] [Full Text] [Related]

  • 12. Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy.
    Das S, Vital EM, Horton S, Bryer D, El-Sherbiny Y, Rawstron AC, Ponchel F, Emery P, Buch MH.
    Ann Rheum Dis; 2014 May 15; 73(5):909-12. PubMed ID: 24385201
    [Abstract] [Full Text] [Related]

  • 13. [Non-TNF biologicals in the therapeutic strategy for rheumatoid arthritis].
    Wollenhaupt J, Krüger K.
    Z Rheumatol; 2010 Sep 15; 69(7):618-25. PubMed ID: 20703488
    [Abstract] [Full Text] [Related]

  • 14. Newer biological agents in the treatment of rheumatoid arthritis: do the benefits outweigh the risks?
    Nurmohamed MT.
    Drugs; 2009 Oct 22; 69(15):2035-43. PubMed ID: 19791825
    [Abstract] [Full Text] [Related]

  • 15. Rheumatoid arthritis: Biological therapy other than anti-TNF.
    Rossi D, Modena V, Sciascia S, Roccatello D.
    Int Immunopharmacol; 2015 Aug 22; 27(2):185-8. PubMed ID: 25840282
    [Abstract] [Full Text] [Related]

  • 16. [The meaning of biologic therapy in the treatment of rheumatoid arthritis with the focus on clinical remission. Part II. Tocilizumab, Abatacept, Rituximab--drugs characterised by a different mechanism of action than TNF-alpha inhibitors].
    Swierkot J, Madej M.
    Pol Merkur Lekarski; 2011 Apr 22; 30(178):289-94. PubMed ID: 21595177
    [Abstract] [Full Text] [Related]

  • 17. Comparative overview of safety of the biologics in rheumatoid arthritis.
    Khraishi M.
    J Rheumatol Suppl; 2009 Jun 22; 82():25-32. PubMed ID: 19509327
    [Abstract] [Full Text] [Related]

  • 18. Targeted therapy in rheumatoid arthritis.
    Köller MD.
    Wien Med Wochenschr; 2006 Jan 22; 156(1-2):53-60. PubMed ID: 16465614
    [Abstract] [Full Text] [Related]

  • 19. Treatment, management, and monitoring of established rheumatoid arthritis.
    Bingham CO, Miner MM.
    J Fam Pract; 2007 Oct 22; 56(10 Suppl Rapid):S1-7; quiz S8. PubMed ID: 17949607
    [No Abstract] [Full Text] [Related]

  • 20. [New therapies for rheumatoid arthritis].
    Salgado E, Maneiro JR.
    Med Clin (Barc); 2014 Nov 18; 143(10):461-6. PubMed ID: 24461738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.